Lillys

Eli Lilly’s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…

Eli Lilly (LLY) shares soared Thursday, after the company’s second-quarter earnings surpassed expectations on booming…